AAREYDRUGS
Invest Now
Start SIP in
AAREYDRUGS
Performance
- Low
- ₹52
- High
- ₹56
- 52 Week Low
- ₹31
- 52 Week High
- ₹75
- Open Price₹53
- Previous Close₹54
- Volume30,253
Investment Returns
- Over 1 Month + 19.22%
- Over 3 Month + 10.54%
- Over 6 Month -16.35%
- Over 1 Year -3.43%
Smart Investing Starts Here Start SIP with Aarey Drugs & Pharmaceuticals for Steady Growth!
Aarey Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 26.4
- PEG Ratio
- 0.3
- Market Cap Cr
- 151
- P/B Ratio
- 1.1
- Average True Range
- 3.18
- EPS
- 2.01
- Dividend Yield
- 0
- MACD Signal
- 3.89
- RSI
- 59.26
- MFI
- 69.9
Aarey Drugs & Pharmaceuticals Financials
Aarey Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹53.16
-0.49
(-0.91%)

-
- Bearish Moving Average 7
-
- Bullish Moving Average 9
- 20 Day
- ₹51.37
- 50 Day
- ₹47.83
- 100 Day
- ₹48.95
- 200 Day
- ₹50.82
Resistance and Support
53.72
- R3 58.24
- R2 56.92
- R1 55.04
- S1 51.84
- S2 50.52
- S3 48.64
Aarey Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-14 | Quarterly Results | |
2024-12-04 | To consider Fund Raising | |
2024-11-29 | Preferential issue of shares | Inter alia: a) To consider a proposal for issuance of equity shares by way of a preferential allotment. |
2024-11-14 | Quarterly Results | |
2024-10-01 | Others |
Aarey Drugs & Pharmaceuticals F&O
About Aarey Drugs & Pharmaceuticals
- NSE Symbol
- AAREYDRUGS
- BSE Symbol
- 524412
- Chairman & Managing Director
- Mr. Mihir R Ghatalia
- ISIN
- INE198H01019
Similar Stocks to Aarey Drugs & Pharmaceuticals
Aarey Drugs & Pharmaceuticals FAQs
Aarey Drugs & Pharmaceuticals share price is ₹53 As on 04 May, 2025 | 14:28
The Market Cap of Aarey Drugs & Pharmaceuticals is ₹150.7 Cr As on 04 May, 2025 | 14:28
The P/E ratio of Aarey Drugs & Pharmaceuticals is 26.4 As on 04 May, 2025 | 14:28
The PB ratio of Aarey Drugs & Pharmaceuticals is 1.1 As on 04 May, 2025 | 14:28
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.